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 he objective of the present study was to characterize bone cells grown in two culture media, and to determine the effective
concentration of OP-1 on the growth of osteo-1 cells. Subcultured rat bone cells (osteo-1) were grown in alpha-modified
Eagle’s minimal essential medium (α-MEM) and Dulbecco’s modified Eagle’s medium (DMEM) and total protein content,
alkaline phosphatase activity and the formation of mineralized nodules were evaluated after 7, 14 and 21 days. Cells were
exposed to different concentrations of rhOP-1 for 1, 3, 5 and 7 days and compared with an untreated control. Osteo-1 cells
presented a significant increase in alkaline phosphatase activity and calcium deposits were observed at 21 days. Cells treated
with 10 and 20 ng/mL rhOP-1 for 24 h showed a significant increase in cell viability when compared to control. Osteo-1 cells
cultured on DMEM demonstrated an osteoblastic phenotype as indicated by high alkaline phosphatase activity and the
presence of calcified nodules. The results suggest that low concentrations of OP-1 may promote an osteogenic effect on
osteo-1 cells.
Uniterms: Osteoblasts; Cell culture techniques; Cell differentiation; Calcification, physiological.
INTRODUCTION
Well-characterized osteoblast cultures provide an
adequate model for the study of cell behavior and for the
determination of biological aspects of the interaction
between materials and bone tissue. However, when isolated,
bone cell lineages lose their morphological identity22.
Various protocols have been established for the
characterization of isolated bone cells, including the
determination of the level of alkaline phosphatase (AP)
activity, specific bone proteins (osteonectin and
osteocalcin) and type I collagen4,18. The ability of isolated
bone cells to produce calcifications also indicates an
osteoblastic phenotype2,19,26.
Deboni, et al.10 (1996) identified and characterized cells
obtained from the calvaria of neonatal albino Wistar rats,
called osteo-1 cells. After first passage, phenotypic
differentiation of the cultures was induced by
supplementation of the medium with 10 mM sodium ß-
glycerophosphate, 50 ìg/mL ascorbic acid and 10-8 M
dexamethasone. The authors confirmed the osteoblastic
nature of the primary cultured cells based on the analysis of
morphology, the presence of AP activity, production of
calcified nodules, and the immunocytochemical expression
of collagen (type I collagen) and non-collagen (osteonectin
and bone sialoprotein II) bone proteins. Since then, osteo-
1 cells have been subcultured and frozen in various
experiments15. However, no study has evaluated the
maintenance of the cellular characteristics that lead to cell
differentiation over time.
Because of the small amount of biological material
available from the first culture, various cell passages are
generally necessary to obtain a sufficient number of cells
for experiments11. In this respect, the maintenance of the
osteoblastic phenotype over serial subcultures is essential.
Some studies have shown the loss of the osteoblastic
phenotype when diploid cells are subcultured8,27.
The expression of a cellular phenotype in culture also
442
J Appl Oral Sci. 2007;15(5):442-7
depends on the biological material used, its manipulation
and culture conditions such as culture medium, time of
growth and the presence of components that influence cell
proliferation and differentiation7,9. Coelho, et al.8 (2000),
analyzing human bone marrow cells, showed similar cell
proliferation in two different culture media but AP activity
and the ability to form mineralized deposits were lower in
the DMEM culture. In both experimental situations,
osteoblastic parameters were strongly reduced on cell
passage, particularly from the first to the second subculture.
Bone morphogenetic protein (BMP) plays a crucial role
in the growth and differentiation of a variety of cell types
including osteoblasts5. Osteogenic protein-1 (OP-1)
promotes the maturation of committed cells to differentiate
into osteoblasts, increases the expression of osteoblast
marker genes and bone-like nodule formation in calvaria-
derived cells, and promotes the differentiation of bone
marrow cells into osteoblastic cells13,20.
Sampath, et al.25 (1992) and Yeh, et al.8 (2004)
demonstrated that OP-1 added to bone cell cultures enriched
with osteoblasts at different stages of differentiation
stimulates cell proliferation, collagen synthesis, induction
of AP and osteocalcin synthesis. However, the effects of
different concentrations of OP-1 at the cellular level have
not been clearly defined.
The objective of the present study was to investigate
whether primary cultured cells obtained from parietal bone
of neonatal rats, called osteo-1, preserve their osteoblastic
phenotype over serial passages or subcultures. In addition,
the behavior of these cells cultured in the presence of
different concentrations of rhOP-1 was analyzed.
MATERIAL AND METHODS
The osteo-1 cell line was derived from the primary culture
of calvaria of neonatal (1 to 4 days old) albino Wistar rats
and obtained by enzymatic isolation, with the culture
medium being supplemented with sodium β-
glycerophosphate, ascorbic acid and dexamethasone after
semi-confluence10. Subcultured and frozen cells from this
cell line, previously identified and characterized by Deboni,
et al.10 (1996), were used in the present experiments. All cells
used in this study were kindly provided by the Laboratory
of Cell Culture, Department of Dentistry, School of Dentistry,
University of São Paulo, and the study was approved by
the Ethics Committee of this Institution.
During the culture period, subcultured and frozen rat
bone cells (osteo-1), primary human bone cells, called osteo-
AF cells, human pulp fibroblasts (FP5), mouse embryo
fibroblasts (NH3T3), human gingival fibroblasts (FMM1)
and canine kidney epithelial cells (MDCK) were maintained
at 37ºC in a humidified atmosphere containing 5% CO
2
 and
95% atmospheric air. The culture media were changed every
2 days. After reaching subconfluence, the cells were
enzymatically removed from the culture flasks using a
solution of 1 nM EDTA (Gibco, Life Technologies, Grand
Island, NY, USA) and 0.25% trypsin (Gibco) and plated at a
concentration of 2 x 104 cells/well onto 24-well culture
plates24 in the first and second experiment.
Three experiments were carried out in the present study:
1) characterization of subcultured and frozen rat bone cells
(osteo-1), 2) analysis of the behavior of osteo-1 cells in two
different culture media, and 3) determination of the effective
concentration of OP-1.
To characterize osteo-1 cells as osteoblasts, osteo-1,
NH3T3, FMM1 and MDCK cells were analyzed regarding
total protein content and AP activity. NH3T3, FMM1 and
MDCK were used as negative controls. The formation of
calcified nodules was evaluated by staining with Alizarin
red S. The cells were grown on DMEM (Sigma Chemical
Co., St. Louis, MO, USA) supplemented with 10% fetal bovine
serum (Cultilab, Campinas, SP, Brazil) and 1% of an antibiotic-
antimycotic solution (Sigma Chemical Co.).
In the second experiment for the evaluation of the
behavior of osteo-1 cells in two different culture media, osteo-
1, osteo-AF, FP5 and FMM1 cultures were compared
regarding total protein content and AP activity. The
following culture media were used: α-MEM (Gibco)
supplemented with 10% fetal bovine serum (Gibco), 50 mg/
mL gentamicin (Gibco), 0.3 mg/mL fungizone (Gibco), 10-7 M
dexamethasone (Sigma), 5 mg/l ascorbic acid (Gibco) and 7
mM β-glycerophosphate (Sigma), called fully supplemented
medium (FSM), and DMEM (Sigma) containing 10% fetal
bovine serum and 1% of an antibiotic-antimycotic solution.
After 7, 14 and 21 days of culture, total protein content
in the culture was calculated according to the modified
method of Lowry16 and AP activity was evaluated by the
release of thymolphthalein monophosphate from
thymolphthalein using a commercial kit (Labtest Diagnostica
AS). At 14 and 21 days, adhered cells were fixed, dehydrated
and processed for staining with Alizarin red S, which stains
calcium-rich areas3.
In the third experiment for the determination of the
effective dose of OP-1, osteo-1 cells were plated at a
concentration of 5 x 102 cells/well onto 96-well culture plates
and treated with the following concentrations: 4, 10, 20, 50
and 100 ng/mL OP-1 (Sigma-Aldrich, St. Louis, MO, USA)
added in DMEM containing 10% fetal bovine serum. Cells
cultured without rhOP-1 served as controls. Cell viability
was calculated after 1, 3, 5 and 7 days by the MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide)
method21. The effect of treatment with OP-1 was assessed
as follows: 1) osteo-1 cells were cultured in medium
containing different concentrations of OP-1, with complete
change of the medium every 2 days, and 2) cells were treated
with different concentrations of OP-1 only on the first day
of the experiment and cells were incubated without OP-1
and the medium was changed every 2 days throughout the
study period.
Data were analyzed by analysis of variance and statistical
significance was determined by the Tukey’s test. A p value
<0.05 was considered to be significant.
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RESULTS
Characterization of osteo-1 cells
The AP activity/total protein content ratio differed
between cell types (ANOVA: F=102.97; d.f.=3.6; p=0.0000),
being higher for osteo-1 cells, and was affected by culture
time (ANOVA: F=4.10; d.f.=2.6; p=0.02), with a higher ratio
being observed at 14 and 21 days (Figure 1). At 14 days, no
production of mineralized matrix was observed for cultured
osteo-1, NH3T3, MDCK or FMM1 cells, whereas at 21 days
only subcultured and frozen osteoblasts (osteo-1 cells)
showed positive Alizarin red S staining (Figure 2).
Behavior of osteo-1 cells on FSM and DMEM
Total protein content differed between bone cells and
fibroblasts cultured on the two media (ANOVA: F=117.78;
d.f.=7.4; p=0.0000), with total protein being higher for osteo-
1 cells grown on DMEM at 21 days and for FMM1 cells
grown on FSM after the same period. Total protein content
was also affected by culture time (ANOVA: F=442.80;
d.f.=2.4; p=0.0000), with 21 > 14 = 7 days (Figure 3A and B).
AP activity differed between bone cells and fibroblasts
cultured on the two media as follows (ANOVA: F=551.90;
d.f.=7.4; p=0.0000): osteo-1 > osteo-AF = FP5 = FMM1 when
grown on DMEM; however, the same order was not
observed when cells were grown on FSM. AP activity differed
between osteo-1 and osteo-AF cells and was affected by
culture time (ANOVA: F=46.51; d.f.=2.4; p=0.0000): osteo-
AF > osteo-1 > FP5 = FMM1, being higher after 21 days
(Figure 4A and B).
FIGURE 2- Photograph showing the formation of a bone
nodule stained with Alizarin red S in an osteo-1 cell culture
at 21 days
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FIGURE 3- Total protein content (µg/mL) of bone cells and
fibroblasts grown on DMEM (A) and FSM (B) after 7, 14 and
21 days of culture. Data are reported as the mean ± standard
deviation of one experiment performed in triplicate
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FIGURE 4- Alkaline phosphatase activity (µmol
thymolphthalein/h/mL) of bone cells and fibroblasts grown
on DMEM (A) and FSM (B) after 7, 14 and 21 days of culture.
Data are reported as the mean ± standard deviation of one
experiment performed in triplicate
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FIGURE 1- Alkaline phosphatase/total protein ratio (µmol
thymolphthalein/µg protein) obtained for the four different
cell types after 7, 14 and 21 days of culture. Data are
reported as the mean ± standard deviation of one
experiment performed in sextuplicate
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Effect of different concentrations of rhOP-1
Cells treated with 10 and 20 ng/mL rhOP-1 on the first
day showed a significant increase in cell viability when
compared to control. No significant difference between the
control and treatment with 100 ng/mL rhOP-1 was observed
at 1, 3 or 7 days (Figures 5 and 6).
The results showed a significant reduction in cell viability
(ANOVA: F=131.32; df=5.72; p=0.0000) between the control
and groups treated with 4, 10, 20 and 50 ng/mL rhOP-1 added
to the medium every 2 days after 3, 5 and 7 days (Figure 5).
When cells were treated with 4, 10, 20 and 50 ng/mL
rhOP-1 only on the first day of the experiment, cell viability
decreased (ANOVA: F=13.81; df=5.72; p=0.0000) compared
to the control at 5 and 7 days (Figure 6).
DISCUSSION
Many biological events associated with bone healing
can be investigated using isolated osteoblastic cells. In the
present two experiments investigating the maintenance of
the osteoblastic phenotype of osteo-1 cells subcultured and
frozen over a period of 10 years, osteo-1 cells showed mean
AP activity levels ranging from 1.5 to 2.5 µmol
thymolphthalein/h/mL when grown on DMEM at 14 and 21
days. The specific time of expression of AP has been shown
to coincide with the process of osteogenesis in the cell
culture model described by Malaval, et al.17 (1994) and Beck
Jr 1(2003).
Beloti, et al.3 (2005) demonstrated a mean AP activity of
0.73 (±0.07) µmol thymolphthalein/h/104 cells after the first
passage of human bone marrow mesenchymal cells cultured
on titanium. The authors also observed the formation of
calcified nodules at 21 days.
Comparison of AP activity between the DMEM and FSM
culture media revealed a significant increase for osteo-1 cells
grown on DMEM, and AP activity differed between osteo-
1 and osteo-AF cells grown on FSM. As the DMEM medium
used was not supplemented with ascorbic acid, β-
glycerophosphate or dexamethasone, osteo-AF cells were
unable to differentiate. In the case of FSM, the presence of
differentiation inducers permitted the expression of AP
activity by osteo-AF cells. On the other hand, no increase
in AP activity was observed for osteo-1 cells which had
been induced previously.
AP activity has been associated with biological
calcifications. In bone cell cultures, mineralization occurs
after activation of AP. In the present study, calcium deposits
demonstrated by positive Alizarin red S staining were only
observed in osteo-1 cultures at 21 days, a finding indicative
of mineralization.
The present results showed that osteo-1 cells produced
significant amounts of total protein irrespective of the
culture medium used or period analyzed. In the experiment
for the characterization of osteo-1 cells, mean total protein
content was 157.81 mg/mL at 14 days. In addition to AP
activity, these data represent a complementary osteoblastic
parameter since bone formation requires high levels of
protein biosynthesis for the production of a protein matrix
for mineralization.
The proliferative capacity of osteo-1 cells was higher on
DMEM than on FSM. Mean total protein content was higher
than 150 mg protein/mL at 21 days when cells were grown
on DMEM, whereas mean total protein was significantly
lower when cells were cultured on FSM (about 103 mg
protein/mL).
The specificity of the studied osteoblastic parameters
was confirmed using fibroblast and epithelial cultures as
negative controls in the experiments.
The results of the present study suggest that low
concentrations of rhOP-1 (10 and 20 ng/mL) stimulated osteo-
1 cell growth on the first day. The increase in cell viability
was statistically significant for rhOP-1 concentrations of 10
and 20 ng/mL when compared to the control at the same
time point, in agreement with Knutsen, et al.14 (1993), who
observed elevated levels of AP activity for OP-1
concentrations ranging from 10 to 30 ng/mL. Sampath, et
al.25 (1992) showed high levels of osteocalcin production
when cells were grown in the presence of 25 ng/mL OP-1
and increased mineralization in osteoblast cultures treated
FIGURE 5- Cell viability (absorbance) of osteo-1 cells treated
with five different concentrations of rhOP-1 in medium
changed every 2 days after 1, 3, 5 and 7 days of culture.
Data are reported as the mean ± standard deviation of one
experiment performed in quadruplicate
FIGURE 6- Cell viability (absorbance) of osteo-1 cells treated
with different concentrations of OP-1 only on the first day of
the experiment and cells incubated without OP-1, the
medium being changed every 2 days, after 1, 3, 5 and 7
days of culture. Data are reported as the mean ± standard
deviation of one experiment performed in quadruplicate
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with 20 ng/mL OP-1, suggesting that this concentration is a
suitable and effective dose. Chaudhary, et al. 6 (2004) and
Yeh, et al.28 (2004) demonstrated that the osteogenic effect
of OP-1 was determined by the time of treatment with OP-1.
Therefore, we added OP-1 at every change of the culture
medium.
Although Fernandes, et al.11 (1997) have shown that AP
activity and the capacity to form mineralized areas decrease
with successive passages, it is important to emphasize that
even after a long period of induction with ascorbic acid, ß-
glycerophosphate and dexamethasone, osteo-1 cells
continued to show the basic specific functions of
osteoblasts, i.e., AP activity and ability of mineralization.
The time of supplementation of the culture medium is
probably an important factor for the induction of cell
differentiation. Although Deboni, et al.10 (1996) observed
that modifications of osteo-1 cells did not represent
phenotypic changes or transformation of the culture able to
originate a continuous or established cell line12 with a finite
life cycle, i.e., cells undergoing senescence and death after
some passages, laboratory observations over the 10 years
of culture of these cells have shown that they behave like
continuous cells showing a certain degree of uniformity
and stability.
CONCLUSIONS
Subcultured and frozen osteo-1 cells showed an
osteoblastic phenotype characterized by the presence of
AP activity and calcified nodules and can be considered a
viable lineage for the use in experiments. The DMEM culture
medium seems to be able to sustain continuous culture of
these cells and to support their differentiation and
mineralization. The presence of low concentrations of OP-1
in the culture medium may promote an osteogenic effect
that it is determined by the time of treatment with BMP.
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